Thelins sikkerhed er vurderet i kliniske forsøg med mere end 1200 patienter med PAH, såvel som i sikkerhedsdata efter markedsføring.
General description Safety of Thelin has been evaluated in clinical trials of more than 1200 patients with PAH, as well as post-marketing safety data.